AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 64 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $950,000 | -66.8% | 500,000 | +181.6% | 0.20% | -47.8% |
| Q2 2019 | $2,858,000 | -52.9% | 177,546 | -8.0% | 0.39% | -29.4% |
| Q1 2019 | $6,074,000 | -8.9% | 192,994 | -4.9% | 0.55% | -26.2% |
| Q4 2018 | $6,666,000 | -25.4% | 202,994 | -31.5% | 0.75% | -26.8% |
| Q3 2018 | $8,935,000 | +89.5% | 296,251 | +68.3% | 1.03% | +57.8% |
| Q2 2018 | $4,716,000 | – | 176,045 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |